Argus Research Maintains Buy on Eli Lilly, Raises Price Target to $165

Argus Research analyst David Toung maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $145 to $165.

Benzinga · 12/30/2019 12:27

Argus Research analyst David Toung maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $145 to $165.